Equillium Inc (EQ)
1.46
-0.03
(-2.01%)
USD |
NASDAQ |
May 01, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
Equillium Max Drawdown (5Y): 98.20% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 98.20% |
| March 31, 2024 | 98.20% |
| February 29, 2024 | 98.20% |
| January 31, 2024 | 98.20% |
| December 31, 2023 | 98.20% |
| November 30, 2023 | 98.20% |
| October 31, 2023 | 98.17% |
| September 30, 2023 | 98.17% |
| August 31, 2023 | 98.17% |
| July 31, 2023 | 98.17% |
| June 30, 2023 | 98.17% |
| May 31, 2023 | 98.17% |
| April 30, 2023 | 97.88% |
| March 31, 2023 | 97.88% |
| February 28, 2023 | 96.87% |
| January 31, 2023 | 96.87% |
| December 31, 2022 | 96.87% |
| November 30, 2022 | 93.77% |
| October 31, 2022 | 93.74% |
| September 30, 2022 | 93.62% |
| August 31, 2022 | 93.62% |
| July 31, 2022 | 93.62% |
| June 30, 2022 | 93.62% |
| May 31, 2022 | 91.77% |
| April 30, 2022 | 90.77% |
| Date | Value |
|---|---|
| March 31, 2022 | 88.72% |
| February 28, 2022 | 88.17% |
| January 31, 2022 | 88.17% |
| December 31, 2021 | 88.17% |
| November 30, 2021 | 88.17% |
| October 31, 2021 | 88.17% |
| September 30, 2021 | 88.17% |
| August 31, 2021 | 88.17% |
| July 31, 2021 | 88.17% |
| June 30, 2021 | 88.17% |
| May 31, 2021 | 88.17% |
| April 30, 2021 | 88.17% |
| March 31, 2021 | 88.17% |
| February 28, 2021 | 88.17% |
| January 31, 2021 | 88.17% |
| December 31, 2020 | 88.17% |
| November 30, 2020 | 88.17% |
| October 31, 2020 | 88.17% |
| September 30, 2020 | 88.17% |
| August 31, 2020 | 88.17% |
| July 31, 2020 | 88.17% |
| June 30, 2020 | 88.17% |
| May 31, 2020 | 88.17% |
| April 30, 2020 | 88.17% |
| March 31, 2020 | 88.17% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
72.84%
Minimum
May 2019
98.20%
Maximum
Nov 2023
90.45%
Average
88.17%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Janux Therapeutics Inc | -- |
| Retractable Technologies Inc | 95.49% |
| Mersana Therapeutics Inc | 96.16% |
| Spero Therapeutics Inc | 96.92% |
| Vera Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -46.29 |
| Beta (5Y) | 1.762 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 206.4% |
| Historical Sharpe Ratio (5Y) | -0.1292 |
| Historical Sortino (5Y) | -0.6074 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.27% |